• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, July 21, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Zeiss increasing HFA3 trade-in discount for Aussie practitioners

by Staff Writer
February 23, 2022
in Business, Company updates & acquisitions, Local, News
Reading Time: 2 mins read
A A
The HFA3 is designed to address workflow challenges and patient congestion.

The HFA3 is designed to address workflow challenges and patient congestion.

Share on FacebookShare on Twitter

Zeiss is offering an increased trade-in discount on all models of its Humphrey Field Analyser 3 (HFA3) until 31 March 2022, to assist clinics with upgrading to its most advanced perimetry technology.

As clinicians and business owners navigate the new normal and plan for post-pandemic success, the company says now is the time to consider newly expanded measures and technologies to reboot the practice.

With perimetry considered a significant diagnostic bottleneck in most clinics, the HFA3 is designed to address workflow challenges and patient congestion by reducing testing time by 30-50% with SITA Faster1.

Zeiss has kicked off its HFA3 promotion to align with RANZCO’s virtual congress (26 February to 1 March). Practitioners can trade in their current perimeter before 31 March 31 2022 to receive an increased trade-in discount.

The company has also placed a small quantity of pre-order stock to facilitate expedited deliveries prior to 30 June 2022.

For clinics wanting to also further reduce the amount of visual field tests performed, Zeiss stated the HFA3’s SITA Faster 24-2C can reduce the number of 10-2 tests conducted when both central and peripheral visual field defects can be detected in one testing regime.2

The 24-2C test can better detect macular defects by testing 10 additional points within the central 10 degrees that align with areas along physiologically relevant nerve fibre bundles known to be susceptible to glaucomatous defects.

Lastly, Guided Progression Analysis (GPA) reports allow a mixture of new and existing testing strategies to support the immediate adoption of the newest SITA Faster 24-2C strategy in your practice.

According to Zeiss, clinics taking advantage of this opportunity will:

  • Minimise patient chin time with SITA Faster
  • Increase clinical confidence with an additional 10 macular testing points of SITA Faster 24-2C.
  • Adopt new testing strategies but maintain continuity with the same GPA reports.
  • Be eligible for temporary full expensing with the ATO3.

To request a HFA3 quotation contact med.au@zeiss.com.

References

  1. Heijl A et al. A New SITA Perimetric Threshold Testing Algorithm: Construction and a Multicenter Clinical Study. Am J Ophthalmol. 2019;198:154-165.
  2. Chakravarti, T, Moghadam, M, Proudfoot, JA, Weinreb, RN, Bowd, C, Zangwill, LM. Agreement between 10-2 and 24-2c Visual Field Test Protocols for Detecting Glaucomatous Central Visual Field Defects. J Glaucoma. 2021;30(6):e285
  3. Please discuss eligibility with your registered tax advisor and refer to: https://www.ato.gov.au/Business/Depreciation-and-capital-expenses-and-allowances/Temporary-full-expensing/

 

Related Posts

RANZCO is teaming up with the RACGP to boost the number of practitioners capable of doing intravitreal injections. Image: kerale/shutterstock.com.

GPs to do intravitreal injections to boost remote eyecare access

by Staff Writer
July 20, 2026

More GPs could soon be upskilled to perform intravitreal injections (IVIs) in a bid to bolster treatment access in rural...

Former owners Ian Bluntish and Joanne Thomas (left) have sold their established practice to Tristan Glover. Images: Holdfastbay Optometry.

Passing the torch, with a little help from ProVision

by Rob Mitchell
July 20, 2026

Buying and selling an optometry practice can be fraught with challenges, but two practitioners have successfully managed the process, with...

The Light Adjustable Lens is now available in Australia and New Zealand. Image: RxSight.

Plenty of interest in RxSight’s Light Adjustable Lens at AUSCRS

by Rob Mitchell
July 17, 2026

RxSight believes Australian cataract surgeons are ready to embrace a technology that has already transformed refractive cataract surgery overseas, using...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited